Treatment of Epidermolysis bullosa acquisita with dupilumab
Article in JDDG Journal der Deutschen Dermatologischen Gesellschaft (August 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review.
Article in The Journal of clinical and aesthetic dermatology (July 2024)
Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease
Article in Frontiers in Immunology (July 2022)